Arteris (AIP) Files Rule 144 for 50,000 Shares on 10/08/2025

Rhea-AI Filing Summary

Arteris, Inc. (AIP) submitted a Rule 144 notice proposing the sale of 50,000 common shares through Morgan Stanley Smith Barney LLC for an aggregate market value of $647,500. The notice lists the company's total outstanding shares as 42,649,917 and an approximate sale date of 10/08/2025. The shares were originally acquired from the issuer in a private transaction on 11/05/2013 and were paid for in cash. The filing also discloses multiple recent sales by related parties and 10b5-1 plans in the past three months, including transactions dated 08/05/2025, 09/02/2025, and 10/06/2025, with amounts ranging up to $1,310,450.00 in gross proceeds for a single sale.

Positive

• Brokered sale through Morgan Stanley Smith Barney LLC provides orderly execution and market access
• Seller acquired shares in 2013 and paid in cash, indicating a completed holding period for Rule 144 considerations
• Proposed block is small at approximately 0.12% of outstanding shares, limiting immediate market impact

Negative

• Multiple recent insider/affiliate sales in the past three months, including large blocks, could signal ongoing liquidity needs
• Filing does not confirm execution; proposed sale is scheduled for 10/08/2025 but completion is not shown

Insights

Corporate Securities Attorney

Standard Rule 144 notice for an affiliate sale; procedural compliance is the focus.

This filing documents a proposed sale under Rule 144 of 50,000 common shares acquired in 2013, showing the seller relied on standard disclosure about material nonpublic information and 10b5-1 plan usage where applicable. The broker and acquisition/payment history are explicitly stated, which are typical compliance details required for a Rule 144 notice.

Key legal dependencies include satisfying holding-period and public-information tests before sale and any aggregation rules tied to other persons. Monitor the actual sale execution on or after 10/08/2025 for completion and any follow-up filings that confirm execution or amendments.

Equity Markets Analyst

Proposed sale equals ~0.12% of outstanding shares; recent affiliate sales show ongoing liquidity events.

The proposed 50,000-share sale represents a small fraction of the 42,649,917 shares outstanding, roughly 0.12%, so direct market impact should be limited in isolation. However, the filing lists several recent sales by the same account and related entities in the past three months, including larger blocks that generated significant gross proceeds.

Watch the actual trade reporting around 10/08/2025 and any continued 10b5-1 activity; clustered insider/affiliate sales over a short period can affect short-term supply and investor perception even if each block is small.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	647500.00	42649917	10/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/05/2013	Private Acquisition from Issuer or an Affiliate	Issuer			50000	11/05/2013	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/06/2025	5755	80570.00
10b5-1 Sales for BAYVIEW LEGACY, LLC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/06/2025	100000	1310450.00
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/03/2025	11821	130864.34
K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/02/2025	7147	78050.96
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/04/2025	2057	17948.35
K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	1246	1552516.00
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	94245	1271120.01
10b5-1 Sales for BAYVIEW LEGACY, LLC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	50000	655995.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AIP Form 144 propose to sell?

The notice proposes sale of 50,000 common shares with an aggregate market value of $647,500 through Morgan Stanley Smith Barney LLC on or about 10/08/2025.

How large is the proposed sale relative to AIP's outstanding shares?

The filing lists 42,649,917 shares outstanding; the 50,000-share block is about 0.12% of that total.

When were the shares being sold originally acquired?

The securities were acquired from the issuer in a private acquisition on 11/05/2013 and payment was made in cash on that date.

Does the filing show prior recent sales by insiders or affiliates?

Yes; the filing discloses multiple sales in the past three months under 10b5-1 plans and direct sales, including transactions dated 08/05/2025, 09/02/2025, and 10/06/2025 with varying gross proceeds.

Does the Form 144 confirm the sale was executed?

No; the filing records a proposed sale date of 10/08/2025 but does not confirm execution or settlement.